Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. With the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the team at Securisyn Medical, she:
Secured $15 million in capital, including $4 million in non-dilutive government funding.
Developed and expanded a product pipeline from one to five devices.
Built an intellectual property portfolio with 12 patents.
Completed two Phase I and subsequent Phase II SBIR contracts.
Achieved 510(k) market clearance for a Class II medical device.
Championed state programs run by the Office of Economic Development and International Trade to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
